Pat Soon-Shiong, Executive Chairman at ImmunityBio, shared on X:
“Lymphocytes matter. ALC count matters
Yet another paper in 2026 showing that when ALC levels fall from radiation, recurrence of cancer occurs. This progression free survival of ALC high vs ALC low is self explanatory. NK cells and T cells protect .”
Title: Treatment-related lymphopenia predicts long-term survival in locally advanced head and neck cancer: Post-Hoc analysis of a randomized phase III trial
Authors: Gulidanna Shayan, Xin Guo, Xiaodong Huang, Kai Wang, Yuan Qu, Ye Zhang, Runye Wu, Xuesong Chen, Jingwei Luo, Jianghu Zhang, Jingbo Wang, Junlin Yi.
See gallery below.

You can also read:
Pretreatment Risk Model for Radiation-Induced Lymphopenia in Stage III NSCLC: Can We Predict Who Benefits From Durvalumab?
